+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Diabetic Neuropathy"

Neuropathic Pain Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neuropathic Pain Drug Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Anticonvulsants Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anticonvulsants Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Diabetic Neuropathy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Diabetic Neuropathy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Neuralgia Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neuralgia Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Diabetic Peripheral Neuropathy Market - Global Forecast 2025-2032 - Product Thumbnail Image

Diabetic Peripheral Neuropathy Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 194 Pages
  • Global
From
Peripheral Neuropathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Peripheral Neuropathy Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 273 Pages
  • Global
From
Paresthesia Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Paresthesia Treatment Market - Global Strategic Business Report

  • Report
  • February 2026
  • 381 Pages
  • Global
From
Pregabalin Market - Global Strategic Business Report - Product Thumbnail Image

Pregabalin Market - Global Strategic Business Report

  • Report
  • February 2026
  • 372 Pages
  • Global
From
Neuropathic Pain Market - Global Strategic Business Report - Product Thumbnail Image

Neuropathic Pain Market - Global Strategic Business Report

  • Report
  • February 2026
  • 386 Pages
  • Global
From
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 276 Pages
  • Global
From
From
Nerve Entrapment Syndrome Market Report 2025 - Product Thumbnail Image

Nerve Entrapment Syndrome Market Report 2025

  • Report
  • May 2025
  • 175 Pages
  • Global
From
Neuropathic Pain Market Report 2025 - Product Thumbnail Image

Neuropathic Pain Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Neuralgia Treatment Market Report 2025 - Product Thumbnail Image

Neuralgia Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Diabetic Neuropathy Market Report 2025 - Product Thumbnail Image

Diabetic Neuropathy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Diabetic Neuropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Neuropathy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Nerve Growth Factor Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Nerve Growth Factor Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Diabetic Neuropathic Pain- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Neuropathic Pain- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

Diabetic Neuropathy is a type of nerve damage caused by diabetes. It is a common complication of diabetes, affecting up to 70% of people with the condition. Symptoms of diabetic neuropathy can include pain, numbness, tingling, and loss of sensation in the feet, legs, and hands. It can also cause problems with balance and coordination, as well as digestive issues. Endocrinologists are medical professionals who specialize in the diagnosis and treatment of endocrine disorders, including diabetes. They are well-equipped to diagnose and treat diabetic neuropathy, as well as provide lifestyle advice to help manage the condition. Companies in the Diabetic Neuropathy market include Novartis, Sanofi, Eli Lilly, Merck, and Pfizer. Show Less Read more